A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Recent news on Pulmozyme


Aradigm: Wall Street Analyst Forum Presentation Transcript  -  May 22, 2007
Seeking Alpha,He was at FDA when product such as Pulmozyme went through approval. Tobramycin was being developed at the time when he was working as a medical reviewer in

Great Strides Walk raises money for cystic fibrosis research  -  Apr 27, 2007
Valley News Network,Hypertonic saline, Pulmozyme, inhaled tobramycin and the airway-clearing vest, the most potent treatments for CF, are all the results of recent research

Cystic-Fibrosis Treatment Hope Emerges  -  Apr 24, 2007
Wall Street Journal (subscription),Genentech Inc.'s inhaled Pulmozyme helps thin the mucus by acting on DNA left by infection-fighting white blood cells, and Novartis AG makes the inhaled

Genentech Announces First Quarter 2007 Results  -  Apr 11, 2007
Genetic Engineering News (press release),Thrombolytics 68 59 15 --------------------------------------- --------- --------- ---------- Pulmozyme(R) 52 49 6

Genentech Q1 2007 Earnings Call Transcript  -  Apr 11, 2007
Seeking Alpha,Finally, Pulmozyme US sales $52 million, up 6%. Now I will turn the call over to Sue. Thanks, Ian. Good afternoon, everyone. The first quarter of 2007 was

Aerovance Tops Off Series C By Garnering $32M Payout  -  Mar 27, 2007
BioWorld Online,While existing CF drugs like Pulmozyme (domase alfa, Genentech Inc.) and TOBI (tobramycin solution for inhalation, Chiron Corp.

Phase II Cystic Fibrosis Study Closes Enrollment  -  Mar 1, 2007
PR Newswire (press release),Pulmozyme is a registered trademark of Genentech Forward-Looking Statements The statements contained in this press release that are not purely historical

Phase II Cystic Fibrosis Study Closes Enrollment  -  Mar 2, 2007
PharmaLive.com (press release),...both Bronchitol and Pulmozyme* together and Pulmozyme* alone. The trial will measure changes in lung function, airway inflammation, infections,

Phase II Cystic Fibrosis Study Closes Enrollment  -  Feb 23, 2007
PipelineReview.com (press release),...three months’ treatment with each of three different therapies – Bronchitol alone, both Bronchitol and Pulmozyme* together and Pulmozyme* alone.

Gilead`s CF inhaler looks strong  -  Dec 20, 2006
Monsters and Critics.com,Based on sales of Genentech`s Pulmozyme and Novartis` TOBI, he estimated aztreonam would generate sales of approximately $200 million.

The Navicor Group Welcomes New Hire  -  Jan 11, 2007
PharmaLive.com (press release),Brown was also a copywriter at GSW Worldwide for 4 years, developing marketing pieces for several accounts including Nutropin and Pulmozyme for Genentech,

Genentech Announces Full Year and Fourth Quarter 2006 Results  -  Jan 10, 2007
PR Newswire (press release),65 Tarceva(R) 107 84 27 402 275 46 Nutropin(R) products 101 95 6 378 370 2 Xolair(R) 117 93 26 425 320 33 Thrombolytics 62 58 7 243 218 11 Pulmozyme(R)

Genentech Q4 2006 Earnings Call Transcript  -  Jan 10, 2007
Seeking Alpha,US sales of Thrombolytics products were $243 million, an 11% increase over the prior year; and US sales of Pulmozyme were $199 million, up 7% over 2005.

Gilead`s CF inhaler looks strong  -  26 Dec 2006
Monsters and Critics.com,Based on sales of Genentech`s Pulmozyme and Novartis` TOBI, he estimated aztreonam would generate sales of approximately $200 million.

New England Journal of Medicine Publishes Data from Pivotal Study ...  -  Dec 14, 2006
PharmaLive.com (press release),...patients in the United States, except for Pulmozyme(R) (dornase alfa, recombinant), which is covered by the Genentech Endowment for Cystic Fibrosis.

New England Journal of Medicine Publishes Data From Pivotal Study ...  -  Dec 14, 2006
PipelineReview.com (press release),...and donates free product to eligible uninsured patients in the United States, except for Pulmozyme®(dornase alfa, recombinant), which is covered by the

Galapagos wins grant for cystic fibrosis programme  -  Nov 27, 2006
OutSourcing-Pharma.com,The first drug developed specifically for cystic fibrosis, Roche/Genentech's Pulmozyme (dornase alfa), was approved in the mid-1990s as a mucus thinning


This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional